Alto Neuroscience (ANRO) Depreciation and Depletion (2024 - 2026)
Alto Neuroscience has reported Depreciation and Depletion over the past 3 years, most recently at $184000.0 for Q1 2026.
- Quarterly results put Depreciation and Depletion at $184000.0 for Q1 2026, up 7.6% from a year ago — trailing twelve months through Mar 2026 was $751000.0 (changed N/A YoY), and the annual figure for FY2025 was $700000.0, up 40.0%.
- Depreciation and Depletion reached $184000.0 in Q1 2026 per ANRO's latest filing, down from $196000.0 in the prior quarter.
- Across five years, Depreciation and Depletion topped out at $200000.0 in Q3 2024 and bottomed at $168000.0 in Q4 2024.
- Median Depreciation and Depletion over the past 3 years was $190000.0 (2025), compared with a mean of $186500.0.
- Peak annual rise in Depreciation and Depletion hit 16.67% in 2025, while the deepest fall reached 0.0% in 2025.
- Over 3 years, Depreciation and Depletion stood at $168000.0 in 2024, then grew by 16.67% to $196000.0 in 2025, then dropped by 6.12% to $184000.0 in 2026.
- Business Quant data shows Depreciation and Depletion for ANRO at $184000.0 in Q1 2026, $196000.0 in Q4 2025, and $200000.0 in Q3 2025.